drugset / Trial / NCT04705350
A Study to Test Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of Zampilimab in Healthy Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics (PK) of zampilimab in healthy study participants.
Timeline
- Start
- 2021-01-11
- Primary completion
- 2021-07-28
- Completion
- 2021-07-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zampilimab | Unknown | — | Intravenous |
Indications
No indication recorded.